Chris Brinzey

Chris has covered the healthcare sector with a focus on the biotechnology and pharmaceutical industries for over two decades. Prior to joining ICR Westwicke in 2015, Chris was a sell-side analyst and spent 20 years as a senior research analyst and member of the portfolio management team for a dedicated $2.5 billion healthcare crossover fund. Chris has invested across both public and private healthcare companies and is using the deep industry knowledge and keen understanding of market dynamics gained from those experiences to help private and public company clients refine corporate strategies, optimize messaging, and develop a compelling investor relations strategy to help navigate the Wall Street ecosystem and drive value.  

Outside of work, Chris is an avid cyclist, runner, skier and recent biotech podcast addict. When not engaged in one of those activities, you will probably find him hiking the White Mountains of New Hampshire with his wife and three daughters.